PT Famon Awal Bros Sedaya (PRAY) Fundamentals 2026 — P/E 54.3x, Revenue Analysis | SniperIQ
PT Famon Awal Bros Sedaya (PRAY) is a ID-listed Healthcare company in Medical - Care Facilities with a market capitalization of Rp10.40T, trading at Rp745.00 on the JKT. This SniperIQ fundamentals page covers PT Famon Awal Bros Sedaya's valuation (P/E 54.3x, P/B 3.2x), profitability (net margin 7.4%), revenue (Rp2.44T in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is PT Famon Awal Bros Sedaya's market cap?
PT Famon Awal Bros Sedaya (PRAY) has a market capitalization of approximately Rp10.40T, trading at Rp745.00 on the JKT. Market cap moves with the live share price.
What is PT Famon Awal Bros Sedaya's P/E ratio?
PT Famon Awal Bros Sedaya's trailing twelve-month P/E ratio is 54.3x, with a price-to-book (P/B) of 3.2x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is PT Famon Awal Bros Sedaya?
PT Famon Awal Bros Sedaya runs a net profit margin of 7.4%, a gross margin of 27.6%, and an operating margin of 10.7%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does PT Famon Awal Bros Sedaya generate?
PT Famon Awal Bros Sedaya reported revenue of Rp2.44T for fiscal year 2025, with net income of Rp211.4B and earnings per share (EPS) of 15.15. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does PT Famon Awal Bros Sedaya pay a dividend?
PT Famon Awal Bros Sedaya does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is PT Famon Awal Bros Sedaya financially healthy?
PT Famon Awal Bros Sedaya carries a debt-to-equity ratio of 0.58x and a current ratio of 1.55x, with a market beta of 0.38. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is PT Famon Awal Bros Sedaya a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For PT Famon Awal Bros Sedaya (PRAY) the key facts are: market cap Rp10.40T, P/E 54.3x, revenue Rp2.44T, 52-week range 535-980. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track PT Famon Awal Bros Sedaya's full fundamentals live
Get PT Famon Awal Bros Sedaya's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.